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Abstract
Background:  Although thyroxin therapy clearly is beneficial to children with frank
hypothyroidism there is little data on the effects of thyroxin in children with compensated or
subclinical hypothyroidism. The objective of this study was to determine the effect of thyroxin
therapy on cognitive function in children with compensated hypothyroidism. The hypothesis was
that thyroxin therapy would change neuropsychological function.
Methods: Eleven patients with a history of sub clinical hypothyroidism entered the study. At the
start of the study, six out of the 11 were on thyroxin therapy, while 5 were off therapy. All patients
underwent a battery of neuropsychological testing and thyroid function tests at the start of study.
Based on the results of thyroid function tests, two of the 5 patients who were off thyroxin were
started back on thyroxin. All of the 6 patients who were on thyroxin were taken off thyroxin. All
patients then underwent repeat neuropsychological testing and thyroid functions after an average
of 91 days.
Results: Thyroxin therapy could not be shown to have an effect on neuropsychological function
in this short term study. Our patients had attention problems as compared to the normal
population. No significant differences were found between our subjects and normal population
standards in verbal processing, visual processing, motor speed/coordination and achievement.
Conclusion: In this small, short term study, thyroxin therapy could not be shown to affect
neuropsychological function in children with compensated hypothyroidism. These children may
have attention problems but appear to have normal verbal and visual processing, motor speed/
coordination and achievement.
Background
A strong relationship exits between thyroid hormone and
brain development. Thyroid hormone therapy has a sig-
nificant long-term impact on child behavior, locomotor
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ability, speech, hearing and cognition in children with
congenital hypothyroidism [1]. In addition, behavioral
problems were a common finding in children and adults
with congenital hypothyroidism before the era of neona-
tal screening [2,3]. While Ilicki and Larsson reported that
Swedish children with congenital hypothyroidism who
were diagnosed by neonatal screen and were given early
treatment displayed average development as compared to
the normal population [4], other studies have demon-
strated persistent deficits. A recent long term follow up
study of children with congenital hypothyroidism by
Rovet suggested that while early detection and treatment
improves intellectual functioning, non-verbal and visuo-
spatial abilities are significantly below that of their sib-
lings, and the differences increase with age [5]. Song et al.
showed that neuropsychological function of children
with congenital hypothyroidism in the post neonatal
screening era was affected by factors associated with etiol-
ogy of disease and timing of normalization of TSH by thy-
roxin treatment [6]. Bargagna et al. showed that 20% of
children with congenital hypothyroidism detected by
neonatal screen and treated early in life showed a general-
ized learning disorder [7]. Simons et al. concluded that
children with severe congenital hypothyroidism treated
early at mean age of 27.5 days (19–57 days) showed defi-
cits in IQ score at age 3 and 5 year of age and these deficits
were still evident at 10 years of age [8]. Derksen-Lubsen
and Verkerk performed a meta-analysis of data based on
seven studies which were carried on patients with congen-
ital hypothyroidism detected by screening and treated
early in life. The meta-analysis demonstrated IQ deficits
despite early detection and treatment [9]. Kooistra et al.
evaluated behavioral characteristics of children with con-
genital hypothyroidism and concluded that "early treated
congenital hypothyroidism is associated with introver-
sion rather than with social negativity" [10].
The studies mentioned above assessed the relationship
between hypothyroidism and psychomotor development
in children with overt congenital hypothyroidism charac-
terized by clear elevations of serum TSH concentration
and low serum T4 concentrations. Data on outcomes of
children with more subtle forms of hypothyroidism are
sparse. Compensated hypothyroidism is defined as a nor-
mal serum thyroxin concentration, a slightly elevated
TSH, and absence of clinical features of hypothyroidism.
Compensated hypothyroidism is sometimes referred to as
"sub clinical hypothyroidism" or "hyperthyrotropine-
mia". Studies of compensated hypothyroidism in children
are few and limited to the natural history [11]. To date, no
study has examined neurocognitive function and the
impact of thyroxin therapy in children with compensated
hypothyroidism. This study evaluated cognitive function
and the effect of thyroxin therapy on cognitive function in
children with compensated hypothyroidism.
Methods
Subjects
Charts of 21 patients identified with compensated
hypothyroidism seen in our institution between 1989 and
2002 were reviewed. Inclusion criteria for compensated
congenital hypothyroidism were: subjects with a T4 con-
centration within the normal range and a TSH concentra-
tion greater than the laboratory normal range but less
than 40 mcU/ml on confirmatory testing. Subjects with
compensated acquired hypothyroidism were identified as
children > 1 yr of age whose serum concentration of T-4
was in the normal range and TSH above the laboratory
normal range but <20 mcU/ml. We excluded subjects with
central hypothyroidism and those at risk for abnormal
psychomotor development for reasons other than con-
genital hypothyroidism (i.e. chromosomal abnormalities,
syndromes). Study protocol and consents were approved
by the Stony Brook Committee on Research Involving
Human Subjects. Parental consent was obtained for all
subjects and assent was obtained for those over 12 years
of age.
Protocol
Subjects were divided into two groups: Group 1 was on
thyroxin therapy at the start of the study and Group 2 was
not on thyroxin therapy at the start of the study. All under-
went neuropsychological testing and thyroid function
testing at the beginning and the end of the study and each
subject served as his/her own control. After initial testing,
those in Group 1 were taken off thyroxin. Thyroid func-
tion tests were repeated in 6–8 weeks to check their thy-
roid status and neuropsychological testing was repeated.
Thyroxin therapy was resumed if their TSH was elevated.
Those in Group 2 also underwent thyroid function assess-
ment and neuropsychological testing at baseline, after
which they were started on thyroxin therapy if the TSH
was still elevated. In 6–8 weeks, thyroid status was re-
checked and neuropsychological testing repeated. The
repetition of the neuropsychological testing was necessary
to determine the effect of thyroxin therapy on neuropsy-
chological function, and in those who remained off thy-
roxin therapy, to determine the practice effect that may
occur with repeat neuropsychological testing. Scores on
the various neuropsychological studies were also com-
pared to age matched normative data derived from the
general population.
Hormone assays
Thyroid function tests were done by commercial assays as
determined by subjects' insurance but were done in the
same laboratory for each subject.
Neuropsychological testing
Neuropsychological tests included the following:BMC Endocrine Disorders 2006, 6:2 http://www.biomedcentral.com/1472-6823/6/2
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1. Differential Abilities Scale (DAS) for general cognitive
function
2. Test of Variables of Attention (TOVA), a measure of sus-
tained attention
3. Tower of Hanoi (TOH), a measure of problem solving,
mental flexibility and working memory
4. Controlled Oral Word Association (COWA), a test of
verbal fluency
5. Purdue Pegboard is a measure of fine motor speed and
dexterity
6. Child Behavior Checklists and Profile (The Teacher
Report Form could not be given as most of the data collec-
tion took place in the summer months)
7. Woodcock-Johnson psycho educational battery- 3rd edi-
tion (WJIII) to assess various aspects of scholastic achieve-
ment
8. Children's Memory Scale (CMS), a test of verbal and
non-verbal learning and memory
9. Judgment of Line Orientation, a non-motor test of spa-
tial judgment
Statistical analysis
The data were analyzed using a repeated measures "Multi-
variate Analysis of Variance" (MANOVA) test. Chi-square
analyses were conducted to determine whether the pro-
portion of children in the current sample were similar or
discrepant in functioning from that which would be
expected in a normal population.
Because of the small sample size, the numbers of variables
under investigation were reduced by the creation of com-
posites. Table I indicates the composite variables and the
variables from which they were formulated. The compos-
ites for each visit were calculated by the arithmetic means
of the variables. Since the age range of children studied
was considerable and not all children were able to per-
form all tests (e.g. Judgment of Line Orientation), some
scores were not available. In these cases, the available
scores were used to represent the mean overall perform-
ance on that composite. Because of the apparent random-
ness of the missing data, it is unlikely that such estimation
techniques have skewed the findings.
Results
Of 21 patients identified with compensated hypothy-
roidism, parents of 14 consented for the study. Eleven
completed the study. Eight of the 11 were diagnosed with
congenital compensated hypothyroidism (diagnosed at
less than 3 months of age). All had been treated with thy-
roxin from infancy but four of these 8 had been taken off
thyroxin therapy after age 3 yr. The other three had
acquired compensated hypothyroidism (diagnosed age >
1 year of age). Two of these 3 were on thyroxin at entry
into the study. BMI of the 11 subjects varied from the 22nd
to 97th% for age (mean ± SD = 64.5 ± 27.9). Thus, none
were obese. Additional characteristics of the patients are
summarized in Table II.
At the start of the study, 6 patients were on thyroxin ther-
apy (Group 1) and 5 patients were not on thyroxin ther-
apy (Group 2). The mean age at the start of the study was
8.1 years (3.6–12.6). Group 1 had a mean T-4 of 128.7
nmol/L (10 mcg/dl) (range: 87.5 – 164.7 nmol/L [6.8–
12.8 mcg/dl]) and mean TSH of 2.7 miu/ml (range 0.97–
5.5) at the start of the study. Group 2 had a mean T-4 of
91.4 nmol/L (7.1 mcg/dl) (range 69.5–113.3 nmol/L
[5.4–8.8 mcg/dl]) and mean TSH of 5 miu/ml (range 2.6–
9.4) at the start of the study. One patient from group 2
declined blood workup prior to the neuropsychological
testing. Of the 5 subjects in group 2, two were placed back
on thyroxin after the first neuropsychological testing
because of an elevated TSH. The remaining 3 now had
normal thyroid function tests and therefore were not
placed on thyroxin. The overall mean time period
between the visit 1 and visit 2 for the neuropsychological
tests was 91 days (60–131).
Effect of thyroxin
Multivariate Analysis of Variance (MANOVA) was con-
ducted to determine if there was a significant difference in
performance on the major composite variables due to
drug status (on/off thyroxin). A separate MANOVA was
performed for each of the two time points. No significant
differences were found due to being on or off thyroxin at
Table 1: Composite Variables and Individual Subtests
Verbal Processing
DAS Verbal
CMS Verbal Memory
Controlled oral word association: animals
Visual Processing/Reasoning
DAS Nonverbal Reasoning
DAS Spatial
CMS Visual Memory
Attention/Executive Processing Efficiency
TOVA
Motor Speed/Coordination
Purdue Pegboard
Academic Achievement
Reading – WJIII Letter Word Identification, Passage 
Comprehension, Word Attack
Mathematics – WJIII Calculation, Applied Problems
Spelling – WJIIIBMC Endocrine Disorders 2006, 6:2 http://www.biomedcentral.com/1472-6823/6/2
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either Visit 1 or 2 for any of the composite variables. Table
III indicates the means for those children on and off thy-
roxin at each of the visits.
A repeated measures analysis of variance was also con-
ducted to determine if children performed differently at
the two time points. Again, there were no significant dif-
ferences for any of the major composite variables. Mean
scores at time 1 were not significantly different from those
at time 2.
Because some children were off thyroxin at both visits, a
separate MANOVA was conducted to determine whether
the scores of this group of children differed from the
scores of children from the other two groups (those that
had either stopped taking the drug after baseline or had
started it after the baseline neuropsychological tests were
completed). Results indicated that this group did not dif-
fer significantly from the other two groups.
Although our overall findings showed no effect of either
drug or time in this sample, one non-significant trend was
noted. The two children who were off thyroxin at baseline
and were on thyroxin at the second study visit, showed a
trend of higher visual processing scores at the second
study visit. Means for visits one and two were 96.92 (SD =
9.78) and 104.17 (SD = 29.93), respectively.
Cognitive and behavioral findings as compared to the 
normal distribution
Additional analyses were conducted to determine if this
sample of children showed differences on the major com-
posite variables as compared to what might be expected
from a distribution of normal children. To analyze these
data, scores on the five major composite variables were
collapsed across visits one and two to create total compos-
ite scores (See Table III).
Chi-square analyses were conducted to determine
whether the proportion of children in the current sample
demonstrated similar or discrepant functioning from
what would be expected in a normal distribution. A cut-
off of 1.5 standard deviations below the mean was chosen
to represent significantly poorer functioning. This cut off
corresponds to a standard score of 78 and represents the
lowest 13.59 % of children in a normal distribution. Sev-
eral interesting findings from the chi-square analyses are
presented below:
Visual processing
Based on the mean composite scores, visual processing
was not significantly different from verbal processing.
This finding was surprising based on previous research
indicating that children with congenital hypothyroidism
showed relative deficits in nonverbal/visual processing
Table 2: Characteristics of subjects. Parentheses indicate range. To convert T4 to mcg/dl divide by 12.87
# Age at diagnosis T-4 at diagnosis nmol/
L
TSH at diagnosis mcu/
ml
Age at initial Rx
Congenital 8 1.0 month (0.4–2.1) 117.1 (75.9–150.5) 11 (7.4–14.9) 1.3 months (0.5–2.6)
Acquired 3 6.8 years (1.2–12.3) 69.5 (65.6–73.4) 8.2 (5.4–12.1) 6.8 years (1.2–12.3)
Table 3: Composite Means and SD (in parentheses) for Children On or Off Thyroxin
Visit 1 Visit 2
Major Area of 
Functioning
On (n = 6) Off (n = 5) All (n = 11) On (n = 2) Off (n = 9) All (n = 11) All (n = 11)
Verbal 
Processing
97.92 (12.97) 94.57 (9.22) 96.39 (11.01) 98.00 (10.84) 104.74 (9.31) 103.51 (9.41) 99.95 (8.95)
Visual 
Processing/
Reasoning
100.28 (17.59) 100.85 (7.92) 100.54 (13.41) 104.17 (29.93) 102.82 (15.52) 103.06 (16.81) 101.80 (14.46)
Attention/
Executive 
Processing 
Efficiency
77.69 (8.31) 80.52 (16.33) 79.26 (12.71) 80.90 (19.66) 80.63 (21.19) 80.68 (19.80) 81.77 (17.66)
Motor Speed/
Coordination
93.07 (12.00) 94.00 (11.12) 93.53 (10.92) 96.00 (13.67) 85.70 (17.94) 87.58 (17.13) 89.47 (14.10)
Academic 
Achievement
109.90 (12.73) 100.07 (7.68) 105.43 (11.45) 99.50 (12.49) 105.04 (11.48) 104.03 (11.22) 104.73 (11.24)
Note: Means presented in standard scores, 100 = 50th percentile. N's may vary.BMC Endocrine Disorders 2006, 6:2 http://www.biomedcentral.com/1472-6823/6/2
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skills. Data for Judgment of Line Orientation represented
too few subjects (n = 6) to be included in the overall visual
processing composite but were reviewed separately. The
strikingly low mean for the Judgment of Line Orientation
test (Mean = 73, SD = 23) indicated the possibility of
problematic visual processing despite the absence of an
overall deficit on the visual processing composite.
Verbal processing
No significant difference was observed on the verbal
processing composite as compared to the normal distribu-
tion. Results indicated overall average verbal abilities in
this sample.
Attention/Executive/Processing
TOVA
Results of the TOVA were most striking in comparison to
the normal distribution based on TOVA normative data.
The chi-square analysis showed that composite scores
were well below that expected of children in a normal
population, χ2 = 84.02, df = 1, p < .01. More detailed
investigation of this finding, through inspection of spe-
cific TOVA variables, is worthy of discussion. The TOVA
contains five major variables: (1) Omission errors (Inat-
tention); (2) Commission errors (Impulsivity); (3)
Response Time; (4) Variability in Response Time; and (5)
Perceptual Sensitivity. Our subjects demonstrated two
major patterns of difficulty. First, across the whole of the
test, they demonstrated abnormalities in Omissions,
Response Speed, Variability and Perceptual Sensitivity,
rather than in Commissions. On the other hand, a major-
ity of the patients also committed an abnormal number of
anticipatory responses during the second half of the test,
which tends to draw such impulsivity by presenting the
target stimulus more frequently in a "Go-No Go" para-
digm. Thus they appear to have displayed a mix of defi-
cient information processing and, when provoked,
impulsivity.
Tower of hanoi visit 1
Data from the Tower of Hanoi test were analyzed sepa-
rately because of concerns of practice effects from visit one
to visit two. These indicated a significant chi-square of χ2
= 15.31, df = 1, p < .01. Scores on Tower 1 were signifi-
cantly lower than would be expected as compared to a
normal distribution. This test involves complex attention
and working memory, and the results thus once again sug-
gest deficits among these children in these areas. It is
worth noting further that our subjects tended to fare
poorly on the Tower of Hanoi not because they made
impulsive (i.e., rule-breaking) errors, but rather because
they were unable to solve the problems efficiently.
Motor Speed/Coordination
The motor speed /coordination composite scores did not
indicate a significant difference as compared to the nor-
mal distribution.
Achievement
Scores on the composite achievement did not differ as
compared to scores expected from a normal distribution
Behavioral functioning
Based on the CBCL, subject profiles were indicative of very
slight elevations in the attention domain, but these were
not significantly worse that the instrument's norms. In
addition, no significant changes were seen on the CBCL
across the course of the study.
Discussion
As primary outcome measure, this study did not reveal an
influence of thyroxin therapy on neurocognitive function
in this small group of children with compensated
hypothyroidism. Similar studies of the effect of thyroxin
supplementation on neurocognitive function in adults
with subclinical hypothyroidism have revealed variable
results, but the largest study found no effect (studies sum-
marized in ref. 12). The developing brain is known to be
more sensitive to thyroxin deprivation than the adult
brain, hence this remains an open question in children.
Since this was a short term study, it is possible that a
longer period of being on or off thyroxin therapy may
have yielded different results. However, for safety consid-
erations, it was considered important to carry out a short
term study before examining the effects of thyroxin with-
drawal and therapy over a longer period in this popula-
tion.
When compared to normative data, the neurocognitive
function testing suggest that even though they may not be
classifiable as having ADHD, our subjects with a history of
compensated hypothyroidism have attention problems.
This is most evident on the TOVA, where a majority of our
subjects performed abnormally, and to a lesser degree on
the TOH, where a significant minority performed outside
the normal range on the first administration. These atten-
tional findings are best described as "sub clinical," in the
sense that they were not confirmed by parent ratings of
behavior in the home.
The specific abnormalities seen on the TOVA and Tower
of Hanoi are worthy of comment. Findings on the TOVA
were mixed, partially indicative of "inattention" and
"slowed and variable processing", i.e., a large proportion
of omission errors, and slow and variable reaction time;
and partially indicative of "impulsivity" in the sense that
a majority of these subjects made anticipatory errors dur-
ing the second half of the test (which provokes theseBMC Endocrine Disorders 2006, 6:2 http://www.biomedcentral.com/1472-6823/6/2
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impulsive errors through frequent target presentation).
Tower of Hanoi findings were mainly notable for ineffi-
cient problem solving rather than impulsive behavior.
There is currently considerable debate within the field of
ADHD research as to the validity of different types of
ADHD categories (Hyperactive, Inattentive, and Com-
bined). Barkley have suggested that the "Inattentive Type"
of ADHD may ultimately be reclassified as an independ-
ent disorder involving cognitive pacing and processing,
while ADHD itself should be more narrowly described as
a disorder fundamentally involving impulse control and
self-regulation (13,14). While our sample size is too small
to provide definite information regarding the exact type of
attention/impulse control problems these children have,
the data do suggest that their basic difficulties may have
more to do with efficient information processing and
problem solving than to impulse control and self-regula-
tory functions.
There is controversy concerning the relationship between
thyroid dysfunction and ADHD. To date, the only clear
association between thyroid dysfunction and ADHD is
seen in children with the syndrome of thyroid hormone
resistance [15]. A recent study found no correlation
between T4 concentrations on neonatal screening and the
later development of ADHD [16]. However, this study did
not report TSH concentration, which is generally a more
sensitive indicator of thyroid dysfunction, and therefore
may have missed those with mild thyroid dysfunction. A
study in rats has shown that transient thyroid depletion in
the newborn period is associated with attention deficit
like behavior later in life [17].
Two important limitations exist in our study. Our sub-
jects' combined composite scores were compared to nor-
mative data derived from the general population rather
than to a control group obtained within the study. In
addition, it is possible that those parents who agreed to
enter their children in the study had doubts about neu-
rodevelopment of their off spring thus introducing a selec-
tion bias. However, this scenario was not suggested by
parent's behavior rating at home. The children with con-
genital compensated hypothyroidism were ascertained
before 2000. Since that time, TSH norms for infants have
been broadened in many laboratories (for example: http:/
/www.questdiagnostics.com/kbase/topic/medtest/
hw28656/results.htm). Thus by current laboratory stand-
ards, some of the infants we diagnosed with compensated
hypothyroidism prior to 2000 would now be considered
normal. However, 5 of the 8 children with compensated
congenital hypothyroidism in our study had been tried off
Thyroxin therapy at a mean age of 3.5 years. Their l-T4 was
97.8 nmol/L (7.6 mcg/dl) (range 82.4–122.3 nmol/L
[6.4–9.5 mcg/dl]) and TSH was 8.8 mcU/ml (range 4.8–
12). Three of the 5 had been restarted on thyroxin because
of the TSH was still elevated suggesting that mild eleva-
tions of TSH in infancy may signal persistent elevations in
TSH later in childhood. The fact that we found significant
deficits in attention and problem solving suggests the pos-
sibility that even minor elevations in TSH may be signifi-
cant.
Conclusion
This study suggests that, despite the absence of behavioral
manifestations of distractibility and hyperactivity, chil-
dren with a history of compensated hypothyroidism may
have significant deficits in attention on clinical measures
(TOVA, TOH) relative to the normal distribution as
defined. However, over the short term, thyroxin replace-
ment does not seem to have an impact on neuropsycho-
logical function.
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